Evidence map›Paper›PMID 37465994›Full record

ArticleJournal of biomedical materials research. Part A2023

In vitro biological responses of plasma nanocoatings for coronary stent applications.

ThiThuHa Phan, John E Jones, Meng Chen, T L Strawn, Hekmat B Khoukaz, Yan Ji, Arun Kumar, Douglas K Bowles, William P Fay, Qingsong Yu

Open access · bronzeAbstract read
In one paragraph

Article in Journal of biomedical materials research. Part A, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

ThiThuHa PhanDepartment of Mechanical and Aerospace Engineering, University of Missouri, Columbia, Missouri, USA.
John E JonesNanova, Inc., Columbia, Missouri, USA.
Meng ChenNanova, Inc., Columbia, Missouri, USA.
T L StrawnDepartment of Medicine, Division of Cardiovascular Medicine, School of Medicine, University of Missouri, Columbia, Missouri, USA.
Hekmat B KhoukazDepartment of Medicine, Division of Cardiovascular Medicine, School of Medicine, University of Missouri, Columbia, Missouri, USA.
Yan JiDepartment of Medicine, Division of Cardiovascular Medicine, School of Medicine, University of Missouri, Columbia, Missouri, USA.
Arun KumarDepartment of Medicine, Division of Cardiovascular Medicine, School of Medicine, University of Missouri, Columbia, Missouri, USA.
Douglas K BowlesDepartment of Biomedical Sciences, University of Missouri, Columbia, Missouri, USA.
William P FayDepartment of Medicine, Division of Cardiovascular Medicine, School of Medicine, University of Missouri, Columbia, Missouri, USA.
Qingsong YuDepartment of Mechanical and Aerospace Engineering, University of Missouri, Columbia, Missouri, USA.ORCID 0000-0002-6985-5969
University of Missouri · USNanova Biomaterials (United States) · US

Funding

Improved long-term biocompatibility of coronary stents by plasma coating processR44HL097485 · NHLBI · NANOVA, INC. · PI CHEN, MENG · 2011 to 2019
$4.6M
NHLBI NIH HHS R44 HL097485
6 · The paper itself

Abstract

In-stent restenosis and thrombosis remain to be long-term challenges in coronary stenting procedures. The objective of this study was to evaluate the in vitro biological responses of trimethylsilane (TMS) plasma nanocoatings modified with NH

Indexed as

Endothelial CellsThrombosisAnimalsBlood CoagulationBlood PlateletsChromium AlloysStentsSwineChromium Alloyscell migrationcoronary stentplasma nanocoatingsplatelet adhesionrestenosis and thrombosis prevention

Identifiers

PMID37465994
PMCPMC10529135
OpenAlexW4384664282

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.